News
10-28-2022, 05:24 AM
In a trial matching new treatments to cancer patients based on the genetic make-up of their tumors, 22% of the patients treated with the AKT inhibitor drug ipatasertib had their tumors shrink.
More... (https://www.news-medical.net/news/20221027/AKT-inhibitor-shows-promise-in-a-trial-matching-new-treatments-to-cancer-patients-based-on-genetic-make-up-of.aspx)
More... (https://www.news-medical.net/news/20221027/AKT-inhibitor-shows-promise-in-a-trial-matching-new-treatments-to-cancer-patients-based-on-genetic-make-up-of.aspx)